I would now like to turn the call over to Liz Krutoholow, VP for Investor Relations. Please go ahead. Thank you. Good afternoon and welcome to Tempus' first quarter 2025 conference call.

I would now like to turn the call over to Liz Krutoholow, VP for Investor Relations. Please go ahead. Thank you. Good afternoon. And welcome to Tempus’ first quarter 2025 conference call.

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced publication of its study ...

(Operator Instructions) Thank you. I would now like to turn the call over to Liz Krutoholow, VP for Investor Relations. Please go ahead. Thank you. Good afternoon and welcome to Tempus' first quarter ...

Tempus enters earnings with strong tailwinds but elevated scrutiny. The stock has surged over 80% in the past six months, and analysts have maintained tight but bullish targets — averaging $61. ...

Tempus AI Inc (NASDAQ:TEM) raised its full-year 2025 revenue guidance to $1.25 billion, indicating confidence in continued growth. Despite revenue growth, the company reported a negative adjusted ...

Tempus AI Inc. TEM during the first quarter secured a multi-million dollar deal to build “the world’s largest foundation model for oncology.” “And this is big for a few reasons,” said ...

The deals call for Pathos AI, another Chicago company co-founded by Lefkofsky, to build the oncology model using Tempus data, for which it will pay Tempus $200 million in data licensing and model ...

Tempus AI Inc. (TEM) reported its first-quarter 2025 earnings, showcasing a robust revenue increase of 75.4% year-over-year, reaching $255.7 million, surpassing the forecast of $248.5 million.

When it comes to shares of Tempus AI (NASDAQ: TEM), many may feel like they're standing on a dock watching the stock sail off to the horizon. It's understandable if you identify with this.